about
Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinomaEngineered recombinant single-chain fragment variable antibody for immunosensors.Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands.Mutational analysis of protein substrate presentation in the post-translational attachment of biotin to biotin domains.Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies.A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.scFv antibody: principles and clinical applicationTherapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen.Single-domain antibody fragments with high conformational stability.Structure based antibody-like peptidomimetics.A conjugate of an anti-midkine single-chain variable fragment to doxorubicin inhibits tumor growth.The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.Construction and bacterial expression of a recombinant single-chain antibody fragment against Wuchereria bancrofti SXP-1 antigen for the diagnosis of lymphatic filariasis.Microbial platform technology for recombinant antibody fragment production: A review.Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors.Efficient tumor targeting by single-domain antibody fragments of camels.Molecular dynamics simulation of the crystallizable fragment of IgG1-insights for the design of FcabsInfluence of format on in vitro penetration of antibody fragments through porcine cornea.Penetration of engineered antibody fragments into the eye.Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related Abeta peptide.In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) FragmentsHybrid (Nano)Materials Meet Supramolecular Chemistry: A Brief Introduction to Basic Terms and ConceptsAntibody-Conjugated Nanoparticles for Biomedical Applications
P2860
Q24804173-7F182039-290A-4CC5-BF3A-4A334C548AFFQ30493157-6437535E-F4E8-4090-ACE5-CB24DB75D5FAQ30882706-39A75E30-F102-407F-BF25-4A5C9CCA27C2Q30947413-29159209-1693-4FC5-AB69-93F549EAD6D7Q34451956-88499F67-3AF1-4E30-9785-2745E5C4D0D3Q34660961-08230CE1-C755-4E7D-8312-50D98C322295Q35852647-9AD5BE99-811A-486A-B45F-DF3F603B7BECQ36623092-BA0A9F73-AB76-4915-B64D-D50BDD1FE430Q36639059-EC854B12-2320-4077-A24F-FFBC78A8B692Q37148681-79B6C74A-2D67-45B2-8502-279F49B30352Q37370904-AFC91408-43BF-48C2-AE5E-73726F4F71E2Q38328927-F6339DB6-6F6A-4D2B-AC4F-7C4224848F4AQ38809844-7B18714E-0272-48D9-9010-4681EF44370BQ38888751-5ED28B68-07E8-4ED2-AABB-D88059111224Q39428042-4B73B014-E819-40B4-A625-ABC622974432Q40018525-8455B597-9D01-4652-AD13-3AAD052C9F81Q40650068-EC1FD737-459A-47F8-98C8-725D43F35988Q41778455-C093E35C-FD17-4D61-9E1C-440366F12B71Q43006942-785620D7-BEA5-4F81-A11E-0DBFA9668A65Q43975336-C790AD0C-4D69-4185-B912-7ED9C2F30555Q48499322-C6FA90F8-56AE-4755-9F5F-0C4850BF1326Q56568322-6FA931F2-3356-4F04-AB76-83557D0065AAQ57401201-E632F686-6B3F-48BB-9827-983A8EEDD476Q58648259-F2D46F75-8A0C-4300-A02D-185CF0D2E590
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Recombinant antibody fragments.
@ast
Recombinant antibody fragments.
@en
type
label
Recombinant antibody fragments.
@ast
Recombinant antibody fragments.
@en
prefLabel
Recombinant antibody fragments.
@ast
Recombinant antibody fragments.
@en
P1476
Recombinant antibody fragments.
@en
P2093
P304
P356
10.1016/S0958-1669(98)80014-1
P577
1998-08-01T00:00:00Z